Literature DB >> 4197754

Immunologic response of man to group B meningococcal polysaccharide vaccines.

F A Wyle, M S Artenstein, B L Brandt, E C Tramont, D L Kasper, P L Altieri, S L Berman, J P Lowenthal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4197754     DOI： 10.1093/infdis/126.5.514

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  131 in total

1.  Outer membrane antigens of Neisseria meningitidis group B serotype 2 studied by crossed immunoelectrophoresis.

Authors:  G E Hoff; C E Frasch
Journal:  Infect Immun       Date:  1979-09       Impact factor: 3.441

2.  Serotypes of Neisseria meningitidis isolated from patients in Norway during the first six months of 1978.

Authors:  E Holten
Journal:  J Clin Microbiol       Date:  1979-02       Impact factor: 5.948

3.  Distribution of surface protein variants among hyperinvasive meningococci: implications for vaccine design.

Authors:  Rachel Urwin; Joanne E Russell; Emily A L Thompson; Edward C Holmes; Ian M Feavers; Martin C J Maiden
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

Review 4.  Bacterial outer membrane vesicles in disease and preventive medicine.

Authors:  Can M Unal; Viveka Schaar; Kristian Riesbeck
Journal:  Semin Immunopathol       Date:  2010-12-12       Impact factor: 9.623

5.  Characterization of native outer membrane vesicles from lpxL mutant strains of Neisseria meningitidis for use in parenteral vaccination.

Authors:  Makda Fisseha; Ping Chen; Brenda Brandt; Todd Kijek; Elizabeth Moran; Wendell Zollinger
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

6.  Monoclonal antibodies against the 70-kilodalton iron-regulated protein of Neisseria meningitidis are bactericidal and strain specific.

Authors:  A Pettersson; B Kuipers; M Pelzer; E Verhagen; R H Tiesjema; J Tommassen; J T Poolman
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

7.  Use of an inhibition enzyme-linked immunosorbent assay for quantification of capsular polysaccharide or proteins in vaccines.

Authors:  Thomas J Inzana; Anna Champion
Journal:  Clin Vaccine Immunol       Date:  2007-01-31

8.  Specificity of the immune response to a modified group B meningococcal polysaccharide conjugate vaccine.

Authors:  Samuel Moore; Esmé K Farley; Peter C Fusco; Francis Michon
Journal:  Clin Vaccine Immunol       Date:  2006-11-01

9.  Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccine.

Authors:  E Rosenqvist; E A Høiby; E Wedege; K Bryn; J Kolberg; A Klem; E Rønnild; G Bjune; H Nøkleby
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

10.  Pathogenesis of neonatal Escherichia coli meningitis: induction of bacteremia and meningitis in infant rats fed E. coli K1.

Authors:  M P Glode; A Sutton; E R Moxon; J B Robbins
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.